biotech / news / / STAT
FDA announces real-time clinical trials.
The FDA has initiated real-time clinical trials where endpoints are reported instantly using cloud technology.
KEY POINTS
- A proof-of-concept real-time trial is underway with AstraZeneca and major cancer centers reporting data live.
- A broader pilot program launching this summer will expand real-time clinical trials and standardize metrics.
- Real-time data streaming aims to cut drug development dead time and accelerate delivery of new treatments.
- Past FDA reforms have already sped drug approvals, including for zongertinib and Otarmeni with rapid timelines.
COMPANIES
Summarized by Newsio from STAT. How we summarize →